Clinical Evidence

First Look at HelioLiver Data

New results recently unveiled from the state-of-the-art CLiMB Trial: “A prospective, blinded, multicenter U.S. evaluation of a multi-analyte blood-based test for the detection of hepatocellular carcinoma (HCC) in patients with cirrhosis.”